Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis.

Callesen, Louise B; Hamfjord, Julian; Boysen, Anders K; Pallisgaard, Niels; Guren, Tormod K; Kure, Elin H; Spindler, Karen-Lise G

Callesen, Louise B; Hamfjord, Julian; Boysen, Anders K; Pallisgaard, Niels; Guren, Tormod K; Kure, Elin H; Spindler, Karen-Lise G.

Afiliação

Callesen LB; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. loucal@rm.dk.
Hamfjord J; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark. loucal@rm.dk.
Boysen AK; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Pallisgaard N; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Guren TK; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Kure EH; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Spindler KG; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.

Br J Cancer ; 127(3): 500-513, 2022 08.

Article em En | MEDLINE | ID: mdl-35440666

Assuntos

DNA Tumoral Circulante; Neoplasias Colorretais; DNA Tumoral Circulante/genética; Neoplasias Colorretais/patologia; Humanos; Prognóstico; Intervalo Livre de Progressão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / DNA Tumoral Circulante Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google